Annual Cash & Cash Equivalents
$35.28 M
-$52.95 M-60.02%
31 December 2023
Summary:
Nektar Therapeutics annual cash & cash equivalents is currently $35.28 million, with the most recent change of -$52.95 million (-60.02%) on 31 December 2023. During the last 3 years, it has fallen by -$163.68 million (-82.27%). NKTR annual cash & cash equivalents is now -86.50% below its all-time high of $261.27 million, reached on 31 December 2005.NKTR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$30.11 M
+$2.17 M+7.76%
30 September 2024
Summary:
Nektar Therapeutics quarterly cash and cash equivalents is currently $30.11 million, with the most recent change of +$2.17 million (+7.76%) on 30 September 2024. Over the past year, it has dropped by -$34.81 million (-53.62%). NKTR quarterly cash and cash equivalents is now -96.70% below its all-time high of $911.13 million, reached on 30 June 2018.NKTR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.0% | -53.6% |
| 3 y3 years | -82.3% | -44.3% |
| 5 y5 years | -81.9% | -62.9% |
NKTR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.3% | +39.9% | -71.5% | +19.4% |
| 5 y | 5 years | -82.3% | +39.9% | -86.7% | +19.4% |
| alltime | all time | -86.5% | +828.3% | -96.7% | +1484.7% |
Nektar Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $30.11 M(+7.8%) |
| June 2024 | - | $27.94 M(-42.6%) |
| Mar 2024 | - | $48.64 M(+37.9%) |
| Dec 2023 | $35.28 M(-60.0%) | $35.28 M(-45.7%) |
| Sept 2023 | - | $64.92 M(+28.0%) |
| June 2023 | - | $50.73 M(-34.1%) |
| Mar 2023 | - | $76.95 M(-12.8%) |
| Dec 2022 | $88.23 M(+249.9%) | $88.23 M(-16.6%) |
| Sept 2022 | - | $105.76 M(+36.4%) |
| June 2022 | - | $77.55 M(+14.0%) |
| Mar 2022 | - | $67.99 M(+169.6%) |
| Dec 2021 | $25.22 M(-87.3%) | $25.22 M(-53.3%) |
| Sept 2021 | - | $54.02 M(-64.5%) |
| June 2021 | - | $152.34 M(+1.5%) |
| Mar 2021 | - | $150.16 M(-24.5%) |
| Dec 2020 | $198.96 M(+106.5%) | $198.96 M(+256.3%) |
| Sept 2020 | - | $55.84 M(-4.1%) |
| June 2020 | - | $58.21 M(-74.4%) |
| Mar 2020 | - | $227.03 M(+135.6%) |
| Dec 2019 | $96.36 M(-50.6%) | $96.36 M(+18.6%) |
| Sept 2019 | - | $81.22 M(-4.9%) |
| June 2019 | - | $85.42 M(-20.0%) |
| Mar 2019 | - | $106.75 M(-45.2%) |
| Dec 2018 | $194.91 M(+3992.9%) | $194.91 M(-12.3%) |
| Sept 2018 | - | $222.26 M(-75.6%) |
| June 2018 | - | $911.13 M(+2517.8%) |
| Mar 2018 | - | $34.80 M(+630.9%) |
| Dec 2017 | $4.76 M(-92.0%) | $4.76 M(-87.5%) |
| Sept 2017 | - | $37.97 M(+135.1%) |
| June 2017 | - | $16.15 M(-31.2%) |
| Mar 2017 | - | $23.48 M(-60.6%) |
| Dec 2016 | $59.64 M(+7.3%) | $59.64 M(-5.8%) |
| Sept 2016 | - | $63.30 M(+13.7%) |
| June 2016 | - | $55.68 M(-23.3%) |
| Mar 2016 | - | $72.55 M(+30.6%) |
| Dec 2015 | $55.57 M(+349.4%) | $55.57 M(+195.3%) |
| Sept 2015 | - | $18.82 M(-9.8%) |
| June 2015 | - | $20.88 M(-83.9%) |
| Mar 2015 | - | $129.45 M(+946.9%) |
| Dec 2014 | $12.37 M(-68.3%) | $12.37 M(-61.4%) |
| Sept 2014 | - | $32.01 M(+4.3%) |
| June 2014 | - | $30.70 M(-5.4%) |
| Mar 2014 | - | $32.44 M(-17.0%) |
| Dec 2013 | $39.07 M(+53.6%) | $39.07 M(-40.3%) |
| Sept 2013 | - | $65.41 M(+57.9%) |
| June 2013 | - | $41.43 M(+45.2%) |
| Mar 2013 | - | $28.53 M(+12.2%) |
| Dec 2012 | $25.44 M(+66.1%) | $25.44 M(+146.1%) |
| Sept 2012 | - | $10.34 M(-92.4%) |
| June 2012 | - | $136.15 M(-8.3%) |
| Mar 2012 | - | $148.49 M(+869.7%) |
| Dec 2011 | $15.31 M(-13.8%) | $15.31 M(-64.4%) |
| Sept 2011 | - | $43.01 M(+269.9%) |
| June 2011 | - | $11.63 M(-48.3%) |
| Mar 2011 | - | $22.48 M(+26.6%) |
| Dec 2010 | $17.75 M(-64.2%) | $17.75 M(+37.6%) |
| Sept 2010 | - | $12.91 M(-44.5%) |
| June 2010 | - | $23.24 M(+13.0%) |
| Mar 2010 | - | $20.57 M(-58.5%) |
| Dec 2009 | $49.60 M | $49.60 M(+51.3%) |
| Sept 2009 | - | $32.78 M(-71.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $114.99 M(-6.0%) |
| Mar 2009 | - | $122.30 M(-21.4%) |
| Dec 2008 | $155.58 M(+103.9%) | $155.58 M(+144.2%) |
| Sept 2008 | - | $63.71 M(+100.2%) |
| June 2008 | - | $31.83 M(-13.2%) |
| Mar 2008 | - | $36.68 M(-51.9%) |
| Dec 2007 | $76.29 M(+19.7%) | $76.29 M(-56.3%) |
| Sept 2007 | - | $174.71 M(+110.9%) |
| June 2007 | - | $82.86 M(-0.3%) |
| Mar 2007 | - | $83.14 M(+30.4%) |
| Dec 2006 | $63.76 M(-75.6%) | $63.76 M(-59.6%) |
| Sept 2006 | - | $157.67 M(+3.7%) |
| June 2006 | - | $151.99 M(-42.0%) |
| Mar 2006 | - | $262.03 M(+0.3%) |
| Dec 2005 | $261.27 M(+714.8%) | $261.27 M(-26.9%) |
| Sept 2005 | - | $357.22 M(+407.6%) |
| June 2005 | - | $70.38 M(+48.1%) |
| Mar 2005 | - | $47.52 M(+48.2%) |
| Dec 2004 | $32.06 M(-49.9%) | $32.06 M(-65.3%) |
| Sept 2004 | - | $92.37 M(+154.7%) |
| June 2004 | - | $36.27 M(-79.9%) |
| Mar 2004 | - | $180.67 M(+182.1%) |
| Dec 2003 | $64.05 M(+83.6%) | $64.05 M(+24.6%) |
| Sept 2003 | - | $51.40 M(-48.7%) |
| June 2003 | - | $100.20 M(+365.5%) |
| Mar 2003 | - | $21.53 M(-38.3%) |
| Dec 2002 | $34.88 M(+13.2%) | $34.88 M(-21.9%) |
| Sept 2002 | - | $44.68 M(+74.3%) |
| June 2002 | - | $25.63 M(-49.5%) |
| Mar 2002 | - | $50.73 M(+64.6%) |
| Dec 2001 | $30.81 M(-77.3%) | $30.81 M(+2.7%) |
| Sept 2001 | - | $30.00 M(-86.6%) |
| June 2001 | - | $223.14 M(+178.8%) |
| Mar 2001 | - | $80.04 M(-41.2%) |
| Dec 2000 | $136.01 M(+306.9%) | $136.01 M(+46.1%) |
| Sept 2000 | - | $93.09 M(+4.9%) |
| June 2000 | - | $88.78 M(-31.6%) |
| Mar 2000 | - | $129.78 M(+288.2%) |
| Dec 1999 | $33.43 M(+34.2%) | $33.43 M(+73.4%) |
| Sept 1999 | - | $19.28 M(+31.4%) |
| June 1999 | - | $14.67 M(-18.6%) |
| Mar 1999 | - | $18.02 M(-27.7%) |
| Dec 1998 | $24.92 M(+66.7%) | $24.92 M(+36.1%) |
| Sept 1998 | - | $18.31 M(-35.7%) |
| June 1998 | - | $28.48 M(+149.9%) |
| Mar 1998 | - | $11.40 M(-23.8%) |
| Dec 1997 | $14.95 M(-19.6%) | $14.95 M(+55.3%) |
| Sept 1997 | - | $9.63 M(-71.0%) |
| June 1997 | - | $33.15 M(-9.6%) |
| Mar 1997 | - | $36.66 M(+97.1%) |
| Dec 1996 | $18.60 M(+389.5%) | $18.60 M(+116.3%) |
| Sept 1996 | - | $8.60 M(+7.5%) |
| June 1996 | - | $8.00 M(+321.1%) |
| Mar 1996 | - | $1.90 M(-50.0%) |
| Dec 1995 | $3.80 M(-63.8%) | $3.80 M(+22.6%) |
| Sept 1995 | - | $3.10 M(-55.1%) |
| June 1995 | - | $6.90 M(-65.5%) |
| Mar 1995 | - | $20.00 M(+90.5%) |
| Dec 1994 | $10.50 M | $10.50 M(+34.6%) |
| Sept 1994 | - | $7.80 M(-34.5%) |
| June 1994 | - | $11.90 M(+440.9%) |
| Mar 1994 | - | $2.20 M |
FAQ
- What is Nektar Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nektar Therapeutics?
- What is Nektar Therapeutics annual cash & cash equivalents year-on-year change?
- What is Nektar Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Nektar Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of NKTR is $35.28 M
What is the all time high annual cash & cash equivalents for Nektar Therapeutics?
Nektar Therapeutics all-time high annual cash & cash equivalents is $261.27 M
What is Nektar Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, NKTR annual cash & cash equivalents has changed by -$52.95 M (-60.02%)
What is Nektar Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NKTR is $30.11 M
What is the all time high quarterly cash and cash equivalents for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly cash and cash equivalents is $911.13 M
What is Nektar Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, NKTR quarterly cash and cash equivalents has changed by -$34.81 M (-53.62%)